We’re doing more together. But what does this mean for our community? Right now, we’re still serving more Texans with ALS than ever before in our history. This is a strong indicator of our connection to the ALS community across the state and how our reach to the ALS...
This year, we are serving more Texans with ALS than ever before. This number has especially grown the past two years, and is a strong indicator of our connection with the ALS community here in Texas. But what does this number of people served actually mean? The...
This year, our ALS community continued to work together to serve Texans with ALS and their families. It’s been a year of constant change, but your commitment never wavered. And because of you, we are serving more Texans with ALS and their families than ever before....
It’s been a year of constant change. But one thing remains the same – our commitment to serving Texans with ALS and their families. Last year, we served more Texans with ALS than ever before – and because of your support, we’re on track to serve even more people in...
Today marks a monumental day for ALS research as the first in-human clinical trials of AT-1501 have begun. AT-1501 is an antibody therapeutic developed by the ALS Therapy Development Institute (ALS TDI), with support from The ALS Association, ALS ONE, and ALS Finding...
